I wonder if its the news of Roche's new drug for early-stage breast cancer that is close to FDA approval .... what is status of Pfe breast-cancer treatment portfolio and its approved fast-tracked developmental drug (PD0332991)?
Nothing went wrong. It's the rotation into Cyclic Plays as Bond Yield Rise. This is only temp. This in my opinion will go much higher when the FED does not start the Taper at the end of the month and interest rates start going back down.